CHIC 2026 Honors Top Healthcare Deals and Financings at Annual Awards Gala
ByAinvest
Wednesday, Apr 1, 2026 9:37 pm ET1min read
GSK--
VOR--
The 12th Annual China Healthcare Investment Conference (CHIC 2026) recognized outstanding achievements in healthcare investment, financing, and deal-making over the past year. Award winners included Insilico Medicine for IPO of the Year, Kailera Therapeutics and Vor Bio for Private Financing of the Year, and Hengrui Pharma-GSK and Innovent-Takeda for Deal of the Year. The conference, held on March 23-24, brought together senior decision-makers from venture capital, private equity, and pharmaceutical industries to discuss innovation in healthcare.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet